Global Cell and Gene Therapy CDMO Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 154

Published Date: 22 Mar 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Cell and   Gene Therapy Contract Development and Manufacturing Organization (CDMO)   services involve companies providing specialized expertise and infrastructure   for the development, manufacturing, and commercialization of cell and gene   therapy products on behalf of biopharmaceutical companies. These services   encompass a range of activities, including process development, analytical   testing, regulatory support, and manufacturing at various scales, from   preclinical to commercial production. CDMOs play a critical role in   accelerating the translation of cell and gene therapies from research to   clinical application by offering tailored solutions to meet the unique   requirements of each therapy, ultimately helping to bring innovative   treatments to patients more efficiently and effectively.

According to our (Global Info Research) latest study, the global Cell and Gene Therapy CDMO Services market size was valued at US$ 5760 million in 2023 and is forecast to a readjusted size of USD 42240 million by 2030 with a CAGR of 32.1% during review period.

Due to complex technical mechanisms, high-threshold process development and large-scale production, strict regulatory requirements, and limited industrialization experience, CGT products are more dependent on CDMOs than traditional pharmaceuticals. Its outsourcing penetration rate exceeds 65%, far exceeding 35% of traditional biologics.

Considering that the production of viral vectors as the core involves very complex processes, is extremely difficult, and has a long preparation cycle, it is expected that the outsourcing rate of CGT will remain high in the future.

This report is a detailed and comprehensive analysis for global Cell and Gene Therapy CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Cell and Gene Therapy CDMO Services market size and forecasts, in consumption value ($ Million), 2019-2030
Global Cell and Gene Therapy CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Cell and Gene Therapy CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Cell and Gene Therapy CDMO Services market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Lonza, Thermo Fisher, WuXi AppTec, Charles River, OxfordBioMedica, BrammerBio, CELLfor CURE, OBiO Technology, GenScript, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Cell and Gene Therapy CDMO Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Cell and Gene Therapy CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Autologous Cell Therapy Products
    Allogeneic Cell Therapy Products

Market segment by Application
    SMBs
    Large Companies

Market segment by players, this report covers
    Catalent
    Lonza
    Thermo Fisher
    WuXi AppTec
    Charles River
    OxfordBioMedica
    BrammerBio
    CELLfor CURE
    OBiO Technology
    GenScript
    Esco
    Nikon
    FUJIFILM
    Pharmaron
    Porton
    Medicilon
    JOINN Laboratories
    Sofpromed
    eXmoor
    OmniaBio
    RoslinCT
    BioCentriq
    PolTREG
    Miltenyi Bioindustry

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy CDMO Services, with revenue, gross margin, and global market share of Cell and Gene Therapy CDMO Services from 2019 to 2024.
Chapter 3, the Cell and Gene Therapy CDMO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell and Gene Therapy CDMO Services market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy CDMO Services.
Chapter 13, to describe Cell and Gene Therapy CDMO Services research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cell and Gene Therapy CDMO Services by Type
        1.3.1 Overview: Global Cell and Gene Therapy CDMO Services Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Cell and Gene Therapy CDMO Services Consumption Value Market Share by Type in 2023
        1.3.3 Autologous Cell Therapy Products
        1.3.4 Allogeneic Cell Therapy Products
    1.4 Global Cell and Gene Therapy CDMO Services Market by Application
        1.4.1 Overview: Global Cell and Gene Therapy CDMO Services Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 SMBs
        1.4.3 Large Companies
    1.5 Global Cell and Gene Therapy CDMO Services Market Size & Forecast
    1.6 Global Cell and Gene Therapy CDMO Services Market Size and Forecast by Region
        1.6.1 Global Cell and Gene Therapy CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Cell and Gene Therapy CDMO Services Market Size by Region, (2019-2030)
        1.6.3 North America Cell and Gene Therapy CDMO Services Market Size and Prospect (2019-2030)
        1.6.4 Europe Cell and Gene Therapy CDMO Services Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size and Prospect (2019-2030)
        1.6.6 South America Cell and Gene Therapy CDMO Services Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Catalent
        2.1.1 Catalent Details
        2.1.2 Catalent Major Business
        2.1.3 Catalent Cell and Gene Therapy CDMO Services Product and Solutions
        2.1.4 Catalent Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Catalent Recent Developments and Future Plans
    2.2 Lonza
        2.2.1 Lonza Details
        2.2.2 Lonza Major Business
        2.2.3 Lonza Cell and Gene Therapy CDMO Services Product and Solutions
        2.2.4 Lonza Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Lonza Recent Developments and Future Plans
    2.3 Thermo Fisher
        2.3.1 Thermo Fisher Details
        2.3.2 Thermo Fisher Major Business
        2.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Product and Solutions
        2.3.4 Thermo Fisher Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Thermo Fisher Recent Developments and Future Plans
    2.4 WuXi AppTec
        2.4.1 WuXi AppTec Details
        2.4.2 WuXi AppTec Major Business
        2.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Product and Solutions
        2.4.4 WuXi AppTec Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 WuXi AppTec Recent Developments and Future Plans
    2.5 Charles River
        2.5.1 Charles River Details
        2.5.2 Charles River Major Business
        2.5.3 Charles River Cell and Gene Therapy CDMO Services Product and Solutions
        2.5.4 Charles River Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Charles River Recent Developments and Future Plans
    2.6 OxfordBioMedica
        2.6.1 OxfordBioMedica Details
        2.6.2 OxfordBioMedica Major Business
        2.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Product and Solutions
        2.6.4 OxfordBioMedica Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 OxfordBioMedica Recent Developments and Future Plans
    2.7 BrammerBio
        2.7.1 BrammerBio Details
        2.7.2 BrammerBio Major Business
        2.7.3 BrammerBio Cell and Gene Therapy CDMO Services Product and Solutions
        2.7.4 BrammerBio Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 BrammerBio Recent Developments and Future Plans
    2.8 CELLfor CURE
        2.8.1 CELLfor CURE Details
        2.8.2 CELLfor CURE Major Business
        2.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Product and Solutions
        2.8.4 CELLfor CURE Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 CELLfor CURE Recent Developments and Future Plans
    2.9 OBiO Technology
        2.9.1 OBiO Technology Details
        2.9.2 OBiO Technology Major Business
        2.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Product and Solutions
        2.9.4 OBiO Technology Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 OBiO Technology Recent Developments and Future Plans
    2.10 GenScript
        2.10.1 GenScript Details
        2.10.2 GenScript Major Business
        2.10.3 GenScript Cell and Gene Therapy CDMO Services Product and Solutions
        2.10.4 GenScript Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 GenScript Recent Developments and Future Plans
    2.11 Esco
        2.11.1 Esco Details
        2.11.2 Esco Major Business
        2.11.3 Esco Cell and Gene Therapy CDMO Services Product and Solutions
        2.11.4 Esco Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Esco Recent Developments and Future Plans
    2.12 Nikon
        2.12.1 Nikon Details
        2.12.2 Nikon Major Business
        2.12.3 Nikon Cell and Gene Therapy CDMO Services Product and Solutions
        2.12.4 Nikon Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Nikon Recent Developments and Future Plans
    2.13 FUJIFILM
        2.13.1 FUJIFILM Details
        2.13.2 FUJIFILM Major Business
        2.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Product and Solutions
        2.13.4 FUJIFILM Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 FUJIFILM Recent Developments and Future Plans
    2.14 Pharmaron
        2.14.1 Pharmaron Details
        2.14.2 Pharmaron Major Business
        2.14.3 Pharmaron Cell and Gene Therapy CDMO Services Product and Solutions
        2.14.4 Pharmaron Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Pharmaron Recent Developments and Future Plans
    2.15 Porton
        2.15.1 Porton Details
        2.15.2 Porton Major Business
        2.15.3 Porton Cell and Gene Therapy CDMO Services Product and Solutions
        2.15.4 Porton Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Porton Recent Developments and Future Plans
    2.16 Medicilon
        2.16.1 Medicilon Details
        2.16.2 Medicilon Major Business
        2.16.3 Medicilon Cell and Gene Therapy CDMO Services Product and Solutions
        2.16.4 Medicilon Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Medicilon Recent Developments and Future Plans
    2.17 JOINN Laboratories
        2.17.1 JOINN Laboratories Details
        2.17.2 JOINN Laboratories Major Business
        2.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Product and Solutions
        2.17.4 JOINN Laboratories Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 JOINN Laboratories Recent Developments and Future Plans
    2.18 Sofpromed
        2.18.1 Sofpromed Details
        2.18.2 Sofpromed Major Business
        2.18.3 Sofpromed Cell and Gene Therapy CDMO Services Product and Solutions
        2.18.4 Sofpromed Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Sofpromed Recent Developments and Future Plans
    2.19 eXmoor
        2.19.1 eXmoor Details
        2.19.2 eXmoor Major Business
        2.19.3 eXmoor Cell and Gene Therapy CDMO Services Product and Solutions
        2.19.4 eXmoor Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.19.5 eXmoor Recent Developments and Future Plans
    2.20 OmniaBio
        2.20.1 OmniaBio Details
        2.20.2 OmniaBio Major Business
        2.20.3 OmniaBio Cell and Gene Therapy CDMO Services Product and Solutions
        2.20.4 OmniaBio Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.20.5 OmniaBio Recent Developments and Future Plans
    2.21 RoslinCT
        2.21.1 RoslinCT Details
        2.21.2 RoslinCT Major Business
        2.21.3 RoslinCT Cell and Gene Therapy CDMO Services Product and Solutions
        2.21.4 RoslinCT Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.21.5 RoslinCT Recent Developments and Future Plans
    2.22 BioCentriq
        2.22.1 BioCentriq Details
        2.22.2 BioCentriq Major Business
        2.22.3 BioCentriq Cell and Gene Therapy CDMO Services Product and Solutions
        2.22.4 BioCentriq Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.22.5 BioCentriq Recent Developments and Future Plans
    2.23 PolTREG
        2.23.1 PolTREG Details
        2.23.2 PolTREG Major Business
        2.23.3 PolTREG Cell and Gene Therapy CDMO Services Product and Solutions
        2.23.4 PolTREG Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.23.5 PolTREG Recent Developments and Future Plans
    2.24 Miltenyi Bioindustry
        2.24.1 Miltenyi Bioindustry Details
        2.24.2 Miltenyi Bioindustry Major Business
        2.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product and Solutions
        2.24.4 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.24.5 Miltenyi Bioindustry Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell and Gene Therapy CDMO Services Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Cell and Gene Therapy CDMO Services by Company Revenue
        3.2.2 Top 3 Cell and Gene Therapy CDMO Services Players Market Share in 2023
        3.2.3 Top 6 Cell and Gene Therapy CDMO Services Players Market Share in 2023
    3.3 Cell and Gene Therapy CDMO Services Market: Overall Company Footprint Analysis
        3.3.1 Cell and Gene Therapy CDMO Services Market: Region Footprint
        3.3.2 Cell and Gene Therapy CDMO Services Market: Company Product Type Footprint
        3.3.3 Cell and Gene Therapy CDMO Services Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cell and Gene Therapy CDMO Services Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Cell and Gene Therapy CDMO Services Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Cell and Gene Therapy CDMO Services Consumption Value Market Share by Application (2019-2024)
    5.2 Global Cell and Gene Therapy CDMO Services Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2030)
    6.2 North America Cell and Gene Therapy CDMO Services Market Size by Application (2019-2030)
    6.3 North America Cell and Gene Therapy CDMO Services Market Size by Country
        6.3.1 North America Cell and Gene Therapy CDMO Services Consumption Value by Country (2019-2030)
        6.3.2 United States Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        6.3.3 Canada Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        6.3.4 Mexico Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2030)
    7.2 Europe Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2030)
    7.3 Europe Cell and Gene Therapy CDMO Services Market Size by Country
        7.3.1 Europe Cell and Gene Therapy CDMO Services Consumption Value by Country (2019-2030)
        7.3.2 Germany Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        7.3.3 France Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        7.3.5 Russia Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        7.3.6 Italy Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Region
        8.3.1 Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Region (2019-2030)
        8.3.2 China Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        8.3.3 Japan Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        8.3.4 South Korea Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        8.3.5 India Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        8.3.7 Australia Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2030)
    9.2 South America Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2030)
    9.3 South America Cell and Gene Therapy CDMO Services Market Size by Country
        9.3.1 South America Cell and Gene Therapy CDMO Services Consumption Value by Country (2019-2030)
        9.3.2 Brazil Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        9.3.3 Argentina Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Country
        10.3.1 Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Country (2019-2030)
        10.3.2 Turkey Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)
        10.3.4 UAE Cell and Gene Therapy CDMO Services Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Cell and Gene Therapy CDMO Services Market Drivers
    11.2 Cell and Gene Therapy CDMO Services Market Restraints
    11.3 Cell and Gene Therapy CDMO Services Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Cell and Gene Therapy CDMO Services Industry Chain
    12.2 Cell and Gene Therapy CDMO Services Upstream Analysis
    12.3 Cell and Gene Therapy CDMO Services Midstream Analysis
    12.4 Cell and Gene Therapy CDMO Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Cell and Gene Therapy CDMO Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Cell and Gene Therapy CDMO Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Cell and Gene Therapy CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Cell and Gene Therapy CDMO Services Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Catalent Company Information, Head Office, and Major Competitors
 Table 6. Catalent Major Business
 Table 7. Catalent Cell and Gene Therapy CDMO Services Product and Solutions
 Table 8. Catalent Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Catalent Recent Developments and Future Plans
 Table 10. Lonza Company Information, Head Office, and Major Competitors
 Table 11. Lonza Major Business
 Table 12. Lonza Cell and Gene Therapy CDMO Services Product and Solutions
 Table 13. Lonza Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Lonza Recent Developments and Future Plans
 Table 15. Thermo Fisher Company Information, Head Office, and Major Competitors
 Table 16. Thermo Fisher Major Business
 Table 17. Thermo Fisher Cell and Gene Therapy CDMO Services Product and Solutions
 Table 18. Thermo Fisher Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. WuXi AppTec Company Information, Head Office, and Major Competitors
 Table 20. WuXi AppTec Major Business
 Table 21. WuXi AppTec Cell and Gene Therapy CDMO Services Product and Solutions
 Table 22. WuXi AppTec Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. WuXi AppTec Recent Developments and Future Plans
 Table 24. Charles River Company Information, Head Office, and Major Competitors
 Table 25. Charles River Major Business
 Table 26. Charles River Cell and Gene Therapy CDMO Services Product and Solutions
 Table 27. Charles River Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Charles River Recent Developments and Future Plans
 Table 29. OxfordBioMedica Company Information, Head Office, and Major Competitors
 Table 30. OxfordBioMedica Major Business
 Table 31. OxfordBioMedica Cell and Gene Therapy CDMO Services Product and Solutions
 Table 32. OxfordBioMedica Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. OxfordBioMedica Recent Developments and Future Plans
 Table 34. BrammerBio Company Information, Head Office, and Major Competitors
 Table 35. BrammerBio Major Business
 Table 36. BrammerBio Cell and Gene Therapy CDMO Services Product and Solutions
 Table 37. BrammerBio Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. BrammerBio Recent Developments and Future Plans
 Table 39. CELLfor CURE Company Information, Head Office, and Major Competitors
 Table 40. CELLfor CURE Major Business
 Table 41. CELLfor CURE Cell and Gene Therapy CDMO Services Product and Solutions
 Table 42. CELLfor CURE Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. CELLfor CURE Recent Developments and Future Plans
 Table 44. OBiO Technology Company Information, Head Office, and Major Competitors
 Table 45. OBiO Technology Major Business
 Table 46. OBiO Technology Cell and Gene Therapy CDMO Services Product and Solutions
 Table 47. OBiO Technology Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. OBiO Technology Recent Developments and Future Plans
 Table 49. GenScript Company Information, Head Office, and Major Competitors
 Table 50. GenScript Major Business
 Table 51. GenScript Cell and Gene Therapy CDMO Services Product and Solutions
 Table 52. GenScript Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 53. GenScript Recent Developments and Future Plans
 Table 54. Esco Company Information, Head Office, and Major Competitors
 Table 55. Esco Major Business
 Table 56. Esco Cell and Gene Therapy CDMO Services Product and Solutions
 Table 57. Esco Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 58. Esco Recent Developments and Future Plans
 Table 59. Nikon Company Information, Head Office, and Major Competitors
 Table 60. Nikon Major Business
 Table 61. Nikon Cell and Gene Therapy CDMO Services Product and Solutions
 Table 62. Nikon Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 63. Nikon Recent Developments and Future Plans
 Table 64. FUJIFILM Company Information, Head Office, and Major Competitors
 Table 65. FUJIFILM Major Business
 Table 66. FUJIFILM Cell and Gene Therapy CDMO Services Product and Solutions
 Table 67. FUJIFILM Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 68. FUJIFILM Recent Developments and Future Plans
 Table 69. Pharmaron Company Information, Head Office, and Major Competitors
 Table 70. Pharmaron Major Business
 Table 71. Pharmaron Cell and Gene Therapy CDMO Services Product and Solutions
 Table 72. Pharmaron Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 73. Pharmaron Recent Developments and Future Plans
 Table 74. Porton Company Information, Head Office, and Major Competitors
 Table 75. Porton Major Business
 Table 76. Porton Cell and Gene Therapy CDMO Services Product and Solutions
 Table 77. Porton Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 78. Porton Recent Developments and Future Plans
 Table 79. Medicilon Company Information, Head Office, and Major Competitors
 Table 80. Medicilon Major Business
 Table 81. Medicilon Cell and Gene Therapy CDMO Services Product and Solutions
 Table 82. Medicilon Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Medicilon Recent Developments and Future Plans
 Table 84. JOINN Laboratories Company Information, Head Office, and Major Competitors
 Table 85. JOINN Laboratories Major Business
 Table 86. JOINN Laboratories Cell and Gene Therapy CDMO Services Product and Solutions
 Table 87. JOINN Laboratories Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 88. JOINN Laboratories Recent Developments and Future Plans
 Table 89. Sofpromed Company Information, Head Office, and Major Competitors
 Table 90. Sofpromed Major Business
 Table 91. Sofpromed Cell and Gene Therapy CDMO Services Product and Solutions
 Table 92. Sofpromed Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 93. Sofpromed Recent Developments and Future Plans
 Table 94. eXmoor Company Information, Head Office, and Major Competitors
 Table 95. eXmoor Major Business
 Table 96. eXmoor Cell and Gene Therapy CDMO Services Product and Solutions
 Table 97. eXmoor Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 98. eXmoor Recent Developments and Future Plans
 Table 99. OmniaBio Company Information, Head Office, and Major Competitors
 Table 100. OmniaBio Major Business
 Table 101. OmniaBio Cell and Gene Therapy CDMO Services Product and Solutions
 Table 102. OmniaBio Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 103. OmniaBio Recent Developments and Future Plans
 Table 104. RoslinCT Company Information, Head Office, and Major Competitors
 Table 105. RoslinCT Major Business
 Table 106. RoslinCT Cell and Gene Therapy CDMO Services Product and Solutions
 Table 107. RoslinCT Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 108. RoslinCT Recent Developments and Future Plans
 Table 109. BioCentriq Company Information, Head Office, and Major Competitors
 Table 110. BioCentriq Major Business
 Table 111. BioCentriq Cell and Gene Therapy CDMO Services Product and Solutions
 Table 112. BioCentriq Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. BioCentriq Recent Developments and Future Plans
 Table 114. PolTREG Company Information, Head Office, and Major Competitors
 Table 115. PolTREG Major Business
 Table 116. PolTREG Cell and Gene Therapy CDMO Services Product and Solutions
 Table 117. PolTREG Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 118. PolTREG Recent Developments and Future Plans
 Table 119. Miltenyi Bioindustry Company Information, Head Office, and Major Competitors
 Table 120. Miltenyi Bioindustry Major Business
 Table 121. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product and Solutions
 Table 122. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 123. Miltenyi Bioindustry Recent Developments and Future Plans
 Table 124. Global Cell and Gene Therapy CDMO Services Revenue (USD Million) by Players (2019-2024)
 Table 125. Global Cell and Gene Therapy CDMO Services Revenue Share by Players (2019-2024)
 Table 126. Breakdown of Cell and Gene Therapy CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 127. Market Position of Players in Cell and Gene Therapy CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 128. Head Office of Key Cell and Gene Therapy CDMO Services Players
 Table 129. Cell and Gene Therapy CDMO Services Market: Company Product Type Footprint
 Table 130. Cell and Gene Therapy CDMO Services Market: Company Product Application Footprint
 Table 131. Cell and Gene Therapy CDMO Services New Market Entrants and Barriers to Market Entry
 Table 132. Cell and Gene Therapy CDMO Services Mergers, Acquisition, Agreements, and Collaborations
 Table 133. Global Cell and Gene Therapy CDMO Services Consumption Value (USD Million) by Type (2019-2024)
 Table 134. Global Cell and Gene Therapy CDMO Services Consumption Value Share by Type (2019-2024)
 Table 135. Global Cell and Gene Therapy CDMO Services Consumption Value Forecast by Type (2025-2030)
 Table 136. Global Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2024)
 Table 137. Global Cell and Gene Therapy CDMO Services Consumption Value Forecast by Application (2025-2030)
 Table 138. North America Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 139. North America Cell and Gene Therapy CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 140. North America Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 141. North America Cell and Gene Therapy CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 142. North America Cell and Gene Therapy CDMO Services Consumption Value by Country (2019-2024) & (USD Million)
 Table 143. North America Cell and Gene Therapy CDMO Services Consumption Value by Country (2025-2030) & (USD Million)
 Table 144. Europe Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 145. Europe Cell and Gene Therapy CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 146. Europe Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 147. Europe Cell and Gene Therapy CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 148. Europe Cell and Gene Therapy CDMO Services Consumption Value by Country (2019-2024) & (USD Million)
 Table 149. Europe Cell and Gene Therapy CDMO Services Consumption Value by Country (2025-2030) & (USD Million)
 Table 150. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 151. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 152. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 153. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 154. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
 Table 155. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value by Region (2025-2030) & (USD Million)
 Table 156. South America Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 157. South America Cell and Gene Therapy CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 158. South America Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 159. South America Cell and Gene Therapy CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 160. South America Cell and Gene Therapy CDMO Services Consumption Value by Country (2019-2024) & (USD Million)
 Table 161. South America Cell and Gene Therapy CDMO Services Consumption Value by Country (2025-2030) & (USD Million)
 Table 162. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 163. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 164. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 165. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 166. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Country (2019-2024) & (USD Million)
 Table 167. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value by Country (2025-2030) & (USD Million)
 Table 168. Global Key Players of Cell and Gene Therapy CDMO Services Upstream (Raw Materials)
 Table 169. Global Cell and Gene Therapy CDMO Services Typical Customers


List of Figures
 Figure 1. Cell and Gene Therapy CDMO Services Picture
 Figure 2. Global Cell and Gene Therapy CDMO Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Cell and Gene Therapy CDMO Services Consumption Value Market Share by Type in 2023
 Figure 4. Autologous Cell Therapy Products
 Figure 5. Allogeneic Cell Therapy Products
 Figure 6. Global Cell and Gene Therapy CDMO Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Cell and Gene Therapy CDMO Services Consumption Value Market Share by Application in 2023
 Figure 8. SMBs Picture
 Figure 9. Large Companies Picture
 Figure 10. Global Cell and Gene Therapy CDMO Services Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 11. Global Cell and Gene Therapy CDMO Services Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 12. Global Market Cell and Gene Therapy CDMO Services Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 13. Global Cell and Gene Therapy CDMO Services Consumption Value Market Share by Region (2019-2030)
 Figure 14. Global Cell and Gene Therapy CDMO Services Consumption Value Market Share by Region in 2023
 Figure 15. North America Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 16. Europe Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 17. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 18. South America Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 19. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 20. Company Three Recent Developments and Future Plans
 Figure 21. Global Cell and Gene Therapy CDMO Services Revenue Share by Players in 2023
 Figure 22. Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 23. Market Share of Cell and Gene Therapy CDMO Services by Player Revenue in 2023
 Figure 24. Top 3 Cell and Gene Therapy CDMO Services Players Market Share in 2023
 Figure 25. Top 6 Cell and Gene Therapy CDMO Services Players Market Share in 2023
 Figure 26. Global Cell and Gene Therapy CDMO Services Consumption Value Share by Type (2019-2024)
 Figure 27. Global Cell and Gene Therapy CDMO Services Market Share Forecast by Type (2025-2030)
 Figure 28. Global Cell and Gene Therapy CDMO Services Consumption Value Share by Application (2019-2024)
 Figure 29. Global Cell and Gene Therapy CDMO Services Market Share Forecast by Application (2025-2030)
 Figure 30. North America Cell and Gene Therapy CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 31. North America Cell and Gene Therapy CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 32. North America Cell and Gene Therapy CDMO Services Consumption Value Market Share by Country (2019-2030)
 Figure 33. United States Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 34. Canada Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 35. Mexico Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 36. Europe Cell and Gene Therapy CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 37. Europe Cell and Gene Therapy CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 38. Europe Cell and Gene Therapy CDMO Services Consumption Value Market Share by Country (2019-2030)
 Figure 39. Germany Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 40. France Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 41. United Kingdom Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 42. Russia Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 43. Italy Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 44. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 45. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 46. Asia-Pacific Cell and Gene Therapy CDMO Services Consumption Value Market Share by Region (2019-2030)
 Figure 47. China Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 48. Japan Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 49. South Korea Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 50. India Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 51. Southeast Asia Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 52. Australia Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 53. South America Cell and Gene Therapy CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 54. South America Cell and Gene Therapy CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 55. South America Cell and Gene Therapy CDMO Services Consumption Value Market Share by Country (2019-2030)
 Figure 56. Brazil Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 57. Argentina Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 58. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 59. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 60. Middle East & Africa Cell and Gene Therapy CDMO Services Consumption Value Market Share by Country (2019-2030)
 Figure 61. Turkey Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 62. Saudi Arabia Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 63. UAE Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 64. Cell and Gene Therapy CDMO Services Market Drivers
 Figure 65. Cell and Gene Therapy CDMO Services Market Restraints
 Figure 66. Cell and Gene Therapy CDMO Services Market Trends
 Figure 67. Porters Five Forces Analysis
 Figure 68. Cell and Gene Therapy CDMO Services Industrial Chain
 Figure 69. Methodology
 Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Catalent
Lonza
Thermo Fisher
WuXi AppTec
Charles River
OxfordBioMedica
BrammerBio
CELLfor CURE
OBiO Technology
GenScript
Esco
Nikon
FUJIFILM
Pharmaron
Porton
Medicilon
JOINN Laboratories
Sofpromed
eXmoor
OmniaBio
RoslinCT
BioCentriq
PolTREG
Miltenyi Bioindustry

Related Reports

Global Cell and Gene Therapy CDMO Services Supply, Demand and Key Producers, 2024-2030

Global Cell and Gene Therapy CDMO Services Supply, Demand and Key Producers, 2024-2030

date 22 Mar 2024

date Medical Care

Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) services involve companies providing specialized expertise and infrastructure for the development, manufacturing, and commercialization of cell and gene therapy products on behalf of biopharmaceutical companies. These services encompass a range of activities, including process development, analytical testing, regulatory support, and manufacturing at various scales, from preclinical to commercial production. CDMOs play a critical role in accelerating the translation of cell and gene therapies from research to clinical application by offering tailored solutions to meet the unique requirements of each therapy, ultimately helping to bring innovative treatments to patients more efficiently and effectively.

Product Tags

Cell and Gene Therapy CDMO Services

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>